Literature DB >> 23268983

The relationship between a Mediterranean diet and circulating adiponectin levels is influenced by cigarette smoking.

Omar Salem Al-Attas1, Tajamul Hussain, Nasser Mohammad Al-Daghri, Edgard De Rosas, Usamah Kazmi, Benjamin Vinodson.   

Abstract

AIM: Adherence to a Mediterranean diet has been shown to lower the risk of developing several chronic diseases. The ability to augment circulating adiponectin levels is proposed as an underlying mechanism mediating the beneficial effects of this diet. We aimed to examine whether the positive relationship between the Mediterranean diet and adiponectin is altered by cigarette smoking, taking potential confounders into consideration.
METHODS: Plasma adiponectin levels were enzymatically measured in 45 never smokers, 61 smokers and 34 ex-smokers who adhered to a Mediterranean style diet and in 41 never smokers who did not adhere to the diet.
RESULTS: Plasma adiponectin levels increased significantly in nonsmoking diet adherents compared to nonsmoking non-diet adherents. Among the diet adherents adiponectin decreased significantly in both moderate and heavy smokers compared to never smokers and significantly increased in quitters compared to smokers. Multiple regression analysis, controlling for age, obesity, Mediterranean diet and insulin resistance revealed an independent inverse association of smoking with adiponectin. Adiponectin levels remained significant and similar in subjects stratified according to age (</>50 years), BMI (</>25 kg/m(2)) and HOMA-IR (</>1.6).
CONCLUSIONS: Despite its positive effects on adiponectin, the Mediterranean diet failed to negate the adiponectin-lowering effect of cigarette smoking, demonstrating the profound and independent capacity of cigarette smoke to negatively influence human health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23268983     DOI: 10.5551/jat.14837

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  4 in total

1.  Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors.

Authors:  R C Li; P Krishnamoorthy; S DerOhannessian; J Doveikis; M Wilcox; P Thomas; D J Rader; M P Reilly; A Van Voorhees; J M Gelfand; N N Mehta
Journal:  Clin Exp Dermatol       Date:  2014-01       Impact factor: 3.470

Review 2.  Specific dietary patterns and concentrations of adiponectin.

Authors:  Vajihe Izadi; Leila Azadbakht
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

3.  Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function.

Authors:  Vanja Ivković; Mislav Jelaković; Mario Laganović; Ivan Pećin; Ana Vrdoljak; Sandra Karanović; Mirjana Fuček; Tamara Božina; Jelena Kos; Tajana Željković Vrkić; Vedran Premužić; Marijana Živko; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 4.  Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2014-06-23       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.